NORTHAMPTON, MA / ACCESSWIRE / October 10, 2024 / Viatris is continuously looking for ways to reduce the volume and types of ...
We recently made a list of 10 Best NASDAQ Stocks Under $20 to Buy. In this piece, we will look at where Viatris Inc.
Novo Nordisk and Viatris have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...
Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the ...
Novo Nordisk (NVO) and Viatris (NASDAQ:VTRS) have reportedly reached an agreement in their dispute over U.S. patents ...
在其他近期新闻中,Viatris Inc.在财务和运营表现方面取得了重大进展。公司最近报告了强劲的2024年第二季度业绩,总收入达到38亿美元,运营收入增长2%。调整后的息税折旧及摊销前利润(EBITDA)上升至12亿美元,调整后每股收益(EPS)报告为0.69美元。这些积极结果使Viatris将2024年新产品收入预测提高到5亿至6亿美元之间。
Viatris (VTRS) reported positive top-line results of Phase 3 study in Japan evaluating the safety and efficacy of EFFEXOR in adults ...
Novo Nordisk ($NVO) and Viatris ($VTRS) have agreed to settle a dispute over patents for Novo’s weight-loss drugs, Ozempic ...
PITTSBURGH, PA / ACCESSWIRE / October 8, 2024 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024.
PITTSBURGH, Oct. 8, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024.
On Tuesday, Viatris Inc (VTRS) stock saw a decline, ending the day at $11.32 which represents a decrease of $-0.01 or -0.09% from the prior close of $11.33. The stock opened at $11.33 and touched a ...